A new treatment for preventing migraines in patients with frequent attacks, and it has shown a good effect withoutany side effects. In American Academy of Neurology annual meeting, a data regarding the phase 3 trial has presented. it was stated as a monthly injection of the drug Erenumab have decreased the number of migraines experienced ...